Analysts expect Silence Therapeutics plc to report revenue of 3.13 M for 2026, against a range of 2.88 M to 3.37 M. The most recent reported year, 2025, came in at 559,000.00, a 92.5% miss against the 7.49 M consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 16.34 M | 21.06 M | 32.47 M | 43.26 M | 559,000.00 | - | - | ||
| High Estimate | 23.64 M | 30.72 M | 38.85 M | 26.79 M | 7.98 M | 3.37 M | 5.20 M | ||
| Low Estimate | 20.03 M | 28.72 M | 35.88 M | 24.79 M | 7.01 M | 2.88 M | 4.26 M | ||
| Consensus Estimate | 21.83 M | 29.72 M | 37.37 M | 25.79 M | 7.49 M | 3.13 M | 4.73 M |
Analysts expect Silence Therapeutics plc to report earnings per share of -0.55 for 2026, against a range of -0.58 to -0.52. The most recent reported year, 2025, came in at -0.63, a 27.6% beat against the -0.87 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.58 | -0.50 | -0.50 | -0.33 | -0.63 | - | - | ||
| High Estimate | -1.11 | -0.39 | -0.40 | -0.64 | -0.80 | -0.52 | -0.62 | ||
| Low Estimate | -1.27 | -0.45 | -0.44 | -0.76 | -0.94 | -0.58 | -0.70 | ||
| Consensus Estimate | -1.19 | -0.42 | -0.42 | -0.70 | -0.87 | -0.55 | -0.66 |